APA (7th ed.) Citation

Monteiro, P., Aguiar, C., Matos, P., Silva-Nunes, J., Birne, R., Branco, P., . . . Polónia, J. (2021). Effect of Empagliflozin Beyond Glycemic Control: Cardiovascular Benefit in Patients with Type 2 Diabetes and Established Cardiovascular Disease.

Chicago Style (17th ed.) Citation

Monteiro, P., C. Aguiar, P. Matos, J. Silva-Nunes, R. Birne, P. Branco, J. Calado, M. Melo, and J. Polónia. Effect of Empagliflozin Beyond Glycemic Control: Cardiovascular Benefit in Patients with Type 2 Diabetes and Established Cardiovascular Disease. 2021.

MLA (8th ed.) Citation

Monteiro, P., et al. Effect of Empagliflozin Beyond Glycemic Control: Cardiovascular Benefit in Patients with Type 2 Diabetes and Established Cardiovascular Disease. 2021.